Advanced Search
Contact | Corporate | Help

Daily news email for August 01, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

Sartorius Stedim Biotech Recognized as Innovations Honoree for FlexMoSys

New Campaign for Rentschler's 'Facility of the Year'

 BioSpace
Array BioPharma, Inc. Pain Drug Fails to Better Existing Treatment

Genes May Be Key for Patients With Multiple Colon Polyps, Brigham and Women's Hospital Study

Hey, I'm Over Here: Men and Women See Things Differently, University of Southern California Study

Large Waistline Linked to Sexual Dysfunction, and Weill Cornell Medical College Study

Even Mild Depression, Anxiety Hurts the Heart, University College London Study

BioSpace - Breaking News
Acetylon Pharmaceuticals Initiates New Phase 1b Clinical Trial of Rocilinostat (ACY-1215) in Combination with Celgene Corporation's Revlimid® (Lenalidomide) and Dexamethasone for Patients with Multiple Myeloma

Pharmacyclics, Inc. Triggers Significant Milestone Payment and Provides Clinical Program Update

InSite Vision Initiates the First Phase 3 Clinical Study of BromSite for the Reduction of Pain and Inflammation after Cataract Surgery

pSivida Corp Reports Alimera Sciences's Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials

Hemispherx Biopharma Files Complete Response With the FDA Regarding Its Ampligen® New Drug Application for Chronic Fatigue Syndrome

Biotech News - Business Wire
Molecular Targeting Technologies, Inc. licenses Novel Targeting agent from Medical College of Wisconsin

Design Concepts, Inc. Expands Product and Service Development Capabilities

BioMimetic Therapeutics, Inc. to Report Second Quarter 2012 Financial Results on August 2

BIO Issues Call for Sessions for 2013 BIO International Convention

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Personal Care Kits and Components

 Biotech News - PR Newswire
Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII

Food Ingredients 2012 coloca em pauta setor que fatura anualmente R$ 2 bilhões

Paragon Bioservices, Inc. Wins The 2012 CMO Leadership Award

The Neurosciences Institute Lab Liquidation Auction

Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
India Preparing to Introduce Price Controls

Amarin Wins FDA Approval of Vascepa

Hyperion Therapeutics Goes Public

Supreme Court Ruling on Healthcare Reform Will Lower Costs

California's Stem Cell Agency Approves $150 Million Grants

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Telcare Signs Licensing Agreement to Market GlucoDynamix-ADMS

Conventus Orthopaedics Completes Enrollment in Multi-Center European Clinical Study of Novel Fracture Implant

Research and Markets: Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies

New Wireless Urine and Temperature Management Systems Receive US Department of Defense Research Grant

Research and Markets: Ventricular Fibrillation Global Clinical Trials Review, H1, 2012

 Clinical Trials - PR Newswire
United States Sports Academy Researchers Present Clinical Trial Results For MusclePharms' Assault Pre-Workout Nutritional Supplement At National Strength & Conditioning Association's National Conference

New Research Shows Prostate Cancer Testing Prevents 17,000 Men from Developing Advanced Prostate Cancer

Die Familie der INGENIO-Herzschrittmacher erhält die CE-Kennzeichnung für den Einsatz bei MRT-Scans

La famiglia di pacemaker INGENIO di Boston Scientific riceveilmarchio CE per la sua compatibilità con la risonanza magnetica

La gamme de stimulateurs cardiaques INGENIO de Boston Scientific obtient le marquage CE pour son utilisation avec l'imagerie par resonance magnetique (IRM)

 CNN Top Stories
8 badminton players disqualified

30-ft. camper plunges into pool

Self-balancing motorcycle unveiled

Prison escape deterrent: Wolfdogs

More than half of U.S. counties now drought disaster zones
Contract Pharma
Halo Completes Mirabel Acquisition

Cytovance Appoints SVP Manufacturing Ops

Financial Report: AMRI

Financial Report: Allergan

Quintiles, Almirall in Marketing Pact

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

 FDA News - Business Wire
pSivida Corp. Reports Alimera's Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials

Luitpold Pharmaceuticals Chooses BioClinica Express EDC

Navidea Biopharmaceuticals Completes License for Parkinson's Disease Imaging Agent

Fake Products Pose Real Dangers

FibroGen's FG-3019 Granted U.S. Orphan Drug Designation for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
FDA Press Releases
FDA warns consumers not to eat cantaloupes from Burch Equipment LLC of North Carolina

FDA approves Tudorza Pressair to treat chronic obstructive pulmonary disease

FDA: More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief

FDA warns consumers not to eat shellfish from Oyster Bay Harbor, Nassau County, NY

FDA approves Afinitor for advanced breast cancer

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

 FierceBiotech
UPDATED: Adimab, Mersana strike deal to make antibody-drug combos for pharma

Array shares crater as pain drug disappoints in PhII

Olympics anti-doping team to pursue biomarkers after the games

Can a new Pfizer find success in its long-struggling R&D division

The top 15 biotech venture investments in H1 2012
FierceBiotech IT
Medidata lands record $100M deal with a Big Pharma

AZ blames IT problems for production backup

Models shed light on cocaine-curbing enzymes

AZ's R&D information chief eyes improved trial success

AstraZeneca taps Amazon-like service for outsourcing research

FierceBiotech Research
Celgene and Eisai drugs jointly killed kidney and breast cancer cells

New white blood cell variation is provocative cancer vaccine target

Another shot at treating Alzheimer's with Dimebon

CIRM favors teamwork with $150M in new stem cell grants

17 universities win NIH cash for tissue chip/drug safety testing

 FiercePharma
Shire, UCB see new-drug growth as Allergan, Hospira fall short

Proxy firm backs half of Icahn's Forest nominees

U.K. drug spending down, scripts up on 'patent dividend'

Can retooled Pfizer deliver on R&D promises

Lupin eyes buyouts up to $500M in U.S. growth push
FiercePharma Manufacturing
Regeneron expands plant to capture surge in Eylea sales

Cherwell expands to meet plate demand as regulators crack down

Dr. Reddy's restores FDA approval in Mexico, but a fraction of its business

Dendreon closing plant, will double output at two others

Internet pharmacy money launderer sought by feds

 FierceVaccines
AstraZeneca wins Fluenz contract in U.K.

Survey: U.S. females fail to finish Merck and GSK HPV shots

NIH awards $5M for heroin addiction, AIDS vaccine

In U.K., Sanofi Pasteur's Pneumovax trumps Pfizer's Prevnar 13

FDA wags finger at Sanofi for no-nos at vaccine plants

 Health News - BizJournals.com
Baxter breaks ground on $1B Georgia plant

Methodist recognized for combating line infections

UTSA scholars named to Fulbright Program

Galderma takes on Watson, Actavis in patent suit

Target, Wells Fargo among top corporate donors nationally
Health News - CNBC
Gout risk goes up as waistline expands

Allergan tops estimates, despite currency headwind

Detox, rehab keep few meth users clean long term

Array BioPharma skids on side effects of pain drug

Uganda's Ebola toll climbs to 16, officials say fears lessen

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Five Is Lucky Number for Pharmacyclics

Cell Therapy Trial for Paralysis Gets FDA OK

New Antimicrobial Compounds Starve Malaria

Dendreon Restructuring to Eliminate 600 Jobs

Merck Serono Begins Job Creation Process
Marketwire - Pharma and Biotech
DHS to Sell SalesKing

Pharma Partnering Dollars Continue to Decline for Biotech, Burrill & Company Reports

SRS Continuity of Care Exchange Platform (SRS CCX(TM)) Automates Quality Reporting, Outcomes Management, and Population Health Improvement for Pine Medical Group

Appature Co-Founder and CEO Kabir Shahani Selected as One of PharmaVOICE's "100 Most Inspiring People in Life-Sciences Industry"

Vista Partners Updates Coverage on Ohr Pharmaceutical, Inc.; Raises Target Price to $3.50

 MassBio News
State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

MLSC 2012 Capital Program Announcement

2012 Tax Incentive Program Announcement

Q&A With Jonathan Thomas

Policy Update

 Medical Pharma - PR Newswire
Texas Health Harris Methodist Hospital Southlake Designated an Aetna Institute of Quality® for Spine Surgery

USANA Health Sciences Appoints New CMO, CPO

The Michael J. Fox Foundation Announces Third Quarter Participants in Partnering Program between Awardees and Industry

IMRIS to hold second quarter 2012 results conference call

Medbox, Inc. Applauds Los Angeles City Council Members for their Support of Medical Marijuana
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
Cost-Cutting Helps Pfizer Beat Expectations

Imagine a World Without AIDS

Helping Patients in Need

The Long, Uphill Battle Against AIDS

Baldness Battle, Fought in the Follicle

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Riassunto: La FDA sceglie la piattaforma I2E di Linguamatics per il text mining

Samenvatting: Linguamatics' I2E tekstanalyseplatform gekozen door FDA

Fitch: Express Scripts Contract has Moderate Effect on ABC & Cardinal's Credit Profiles

FDA entscheidet sich für I2E Text Mining von Linguamatics

Forest Laboratories Comments on ISS Report

 Pharma News - PharmiWeb
Innovative and Secure Cloud Based Archiving Solution for European Hospitals

Bring the Vote Home Initiative Helps Seniors, Home-Bound Patients Exercise Their Right to Vote During 2012 Election Cycle

Jersey Shore's Matthew Kaufman, M.D. Is Selected To Present At The European Respiratory Society's 2012 Vienna Congress

FRC Action: 'President Obama to freedom of religion: Nertz to you!'

Safra announces offer to purchase publicly held registered B shares of Sarasin

 Pharma News - PR Newswire
Genelex Receives First Patent on Business Methods for Pharmacogenetics

Wave of Celebrity Support Boosts Global Effort to Eliminate Seven Diseases by 2020

Medical Marijuana Inc. and Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development

The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain

Qforma Chief Technologist Honored as One of PharmaVOICE Magazine's "100 Most Inspiring People in the Life Sciences"
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
USAID/USP's New Research Reveals Extent of Poor-Quality...

360 Vantage CEO Named to 2012 PharmaVOICE 100 List for Leadership,...

Complete Agenda Released for Integrating Sample Preparation 2012...

A 3D Human Skin Equivalent System with Co-Cultures And Vascularized...

First Rugged, Wireless Time Clock Invades Canadian Construction Sites
PRWeb - Pharmaceuticals
MIDEGO Inc. Presents: The Teleclass for Global Health Leaders with...

Atlantic Information Services's Bookshelf Features Newly Updated Full...

Platinum Haze Herbal Incense Has Taken Australia by Storm

RxLogix Launches Actionable Intelligence and Management Product -...

Aspire LLC Announces the Release of Aspire eCTD

 Scientific American
Beak Heat: Evolutionary Theory of Bird Bills Need May Need Revision

Facet-Lift: Self-Assembling Nanoparticles May Provide Key to New Materials

High-Profile Geneticists Post Findings on Popular Pre-Publication Site

9 Theoretical Physicists Win Massive New Cash Award

Women's Risk of Reproductive Disease Linked to Environmental Estrogens

 Sports - ESPN Basketball
Wake Forest to play two exhibitions in Canada

Former coaches Pearl, Greenberg joining ESPN

Colangelo still hopes Coach K will be back in '16

Iona recruit Haynes shot and killed in Chicago

Ex-Hoosier Reed, figure in Knight's firing, dies
Sports News - ESPN
Sandusky upset over Penn State sanctions

Badgers RB Ball victim of 'unprovoked attack'

Penn State LB Fortt transferring to California

Florida St. kicks CB Reid off team after arrest

Report: Penn State loses DT recruit to Rutgers

 Xconomy Life Sciences
Gladstone, Sage Bionetworks Top Best Places to Work List

Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut

Brightcove, Avalon, Bit9, & More from the Boston Deals Roundup

Brightcove, Avalon, Bit9, & More from the Boston Life Sciences Roundup

Avalon Ventures, Coming Off Zynga Investment, Raising 10th Fund

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012